Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q3 2017 13F Holders as of 30 Sep 2017
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 92,799,600
- Total 13F shares
- 9,321,729
- Share change
- -603,086
- Total reported value
- $27,499,118
- Price per share
- $2.95
- Number of holders
- 31
- Value change
- -$1,981,003
- Number of buys
- 8
- Number of sells
- 14
Report period
Q3 2017
Institutions
31
Top holders
10
XENE full security history
Newer quarter: Q4 2017
Previous quarter: Q2 2017
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Top shareholders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
3.8%
|
3,518,830
|
$11,084,000 | — | 30 Jun 2017 | |
| Capital World Investors |
13F
|
Company |
1.5%
|
1,429,000
|
$4,501,000 | — | 30 Jun 2017 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.78%
|
723,853
|
$2,280,000 | — | 30 Jun 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.68%
|
634,812
|
$2,000,000 | — | 30 Jun 2017 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.48%
|
441,260
|
$1,390,000 | — | 30 Jun 2017 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.41%
|
377,695
|
$1,190,000 | — | 30 Jun 2017 | |
| Invesco Private Capital, Inc. |
13F
|
Company |
0.4%
|
375,784
|
$1,184,000 | — | 30 Jun 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.38%
|
350,000
|
$1,103,000 | — | 30 Jun 2017 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
310,808
|
$979,000 | — | 30 Jun 2017 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.33%
|
310,179
|
$977,000 | — | 30 Jun 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.25%
|
228,029
|
$718,000 | — | 30 Jun 2017 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
0.18%
|
164,510
|
$518,000 | — | 30 Jun 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.16%
|
150,000
|
$473,000 | — | 30 Jun 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.14%
|
130,300
|
$410,000 | — | 30 Jun 2017 | |
| Novo Holdings A/S |
13F
|
Company |
0.14%
|
127,563
|
$402,000 | — | 30 Jun 2017 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
125,000
|
$394,000 | — | 30 Jun 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
82,242
|
$259,000 | — | 30 Jun 2017 | |
| J. Goldman & Co LP |
13F
|
Company |
0.08%
|
72,400
|
$228,000 | — | 30 Jun 2017 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.07%
|
65,000
|
$205,000 | — | 30 Jun 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
56,173
|
$177,000 | — | 30 Jun 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.06%
|
55,000
|
$173,000 | — | 30 Jun 2017 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.04%
|
35,629
|
$112,000 | — | 30 Jun 2017 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.03%
|
31,500
|
$99,000 | — | 30 Jun 2017 | |
| Virtu KCG Holdings LLC |
13F
|
Company |
0.03%
|
23,367
|
$74,000 | — | 30 Jun 2017 | |
| NJ State Employees Deferred Compensation Plan |
13F
|
Company |
0.02%
|
20,000
|
$63,000 | — | 30 Jun 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
19,277
|
$61,000 | — | 30 Jun 2017 | |
| Leith Wheeler Investment Counsel Ltd. |
13F
|
Company |
0.02%
|
16,075
|
$51,000 | — | 30 Jun 2017 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
15,829
|
$49,000 | — | 30 Jun 2017 | |
| Dynamic Technology Lab Private Ltd |
13F
|
Company |
0.01%
|
13,001
|
$41,000 | — | 30 Jun 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
10,816
|
$34,000 | — | 30 Jun 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
10,700
|
$33,000 | — | 30 Jun 2017 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
0.01%
|
8,293
|
$26,000 | — | 30 Jun 2017 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
5,530
|
$17,000 | — | 30 Jun 2017 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,655
|
$11,000 | — | 30 Jun 2017 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,530
|
$8,000 | — | 30 Jun 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,464
|
$8,000 | — | 30 Jun 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
738
|
$2,000 | — | 30 Jun 2017 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
700
|
$2,000 | — | 30 Jun 2017 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
40
|
$126 | — | 30 Jun 2017 |
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Shares (XENE) as of Q3 2017
As of 30 Sep 2017,
Xenon Pharmaceuticals Inc. - Common Shares (XENE) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,321,729 shares.
The largest 10 holders included
BVF INC/IL, Capital World Investors, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., DAFNA Capital Management LLC, Invesco Private Capital, Inc., Tekla Capital Management LLC, Point72 Asset Management, L.P., SABBY MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
39
Q3 2017 holders
31
Holder diff
-8
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 Value $ | Q3 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.